Literature DB >> 34878900

How Low Should You Go in the Presence of Frailty?

Michelle C Odden1,2, Timothy S Anderson3.   

Abstract

Entities:  

Keywords:  Editorials; blood pressure; frailty; mortality; phenotype; sample size

Mesh：

Year:  2021        PMID： 34878900      PMCID： PMC8730673          DOI： 10.1161/HYPERTENSIONAHA.121.18373

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   9.897


× No keyword cloud information.
  16 in total

Review 1.  Blood Pressure in Older Adults: the Importance of Frailty.

Authors:  Michelle C Odden; Pamela R Beilby; Carmen A Peralta
Journal:  Curr Hypertens Rep       Date:  2015-07       Impact factor: 5.369

2.  Walking speed is a useful marker of frailty in older persons--reply.

Authors:  Michelle C Odden; Carmen A Peralta; Kenneth E Covinsky
Journal:  JAMA Intern Med       Date:  2013-02-25       Impact factor: 21.873

Review 3.  Promoting higher blood pressure targets for frail older adults: a consensus guideline from Canada.

Authors:  Laurie Herzig Mallery; Michael Allen; Isobel Fleming; Kim Kelly; Susan Bowles; Jill Duncan; Paige Moorhouse
Journal:  Cleve Clin J Med       Date:  2014-07       Impact factor: 2.321

4.  Generalizability of Clinical Trials Supporting the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.

Authors:  Timothy S Anderson; Michelle Odden; Joanne Penko; Dhruv S Kazi; Brandon K Bellows; Kirsten Bibbins-Domingo
Journal:  JAMA Intern Med       Date:  2020-05-01       Impact factor: 21.873

5.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

6.  Frailty index and sex-specific six-year mortality in community dwelling older people - the ActiFE Study.

Authors:  Dhayana Dallmeier; Ulrike Braisch; Kilian Rapp; Jochen Klenk; Dietrich Rothenbacher; Michael Denkinger
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-02-21       Impact factor: 6.053

7.  Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.

Authors:  Weili Zhang; Shuyuan Zhang; Yue Deng; Shouling Wu; Jie Ren; Gang Sun; Jinfeng Yang; Yinong Jiang; Xinjuan Xu; Tzung-Dau Wang; Youren Chen; Yufeng Li; Lianchen Yao; Dianfang Li; Lixin Wang; Xiaomei Shen; Xinhua Yin; Wei Liu; Xiaoyang Zhou; Bingpo Zhu; Zihong Guo; Hualing Liu; Xiaoping Chen; Yingqing Feng; Gang Tian; Xiuyin Gao; Kazuomi Kario; Jun Cai
Journal:  N Engl J Med       Date:  2021-08-30       Impact factor: 91.245

8.  Systolic Blood Pressure and Mortality in Community-Dwelling Older Adults: Frailty as an Effect Modifier.

Authors:  Kaj-Marko Kremer; Ulrike Braisch; Dietrich Rothenbacher; Michael Denkinger; Dhayana Dallmeier
Journal:  Hypertension       Date:  2021-10-25       Impact factor: 10.190

9.  Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.

Authors:  Jeff D Williamson; Mark A Supiano; William B Applegate; Dan R Berlowitz; Ruth C Campbell; Glenn M Chertow; Larry J Fine; William E Haley; Amret T Hawfield; Joachim H Ix; Dalane W Kitzman; John B Kostis; Marie A Krousel-Wood; Lenore J Launer; Suzanne Oparil; Carlos J Rodriguez; Christianne L Roumie; Ronald I Shorr; Kaycee M Sink; Virginia G Wadley; Paul K Whelton; Jeffrey Whittle; Nancy F Woolard; Jackson T Wright; Nicholas M Pajewski
Journal:  JAMA       Date:  2016-06-28       Impact factor: 56.272

10.  No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over.

Authors:  Jane Warwick; Emanuela Falaschetti; Kenneth Rockwood; Arnold Mitnitski; Lutgarde Thijs; Nigel Beckett; Christopher Bulpitt; Ruth Peters
Journal:  BMC Med       Date:  2015-04-09       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.